The CEO of Pfizer says they are almost ready to submit data to U.S. regulators to obtain federal authorization for the COVID-19 vaccine to be administered to children between the ages of 5 and 11.
As Delta continues to target children and spread in schools, the authorization couldn’t come at a better time.
The doses given to children during trials were lower than those given to teenagers and adults, and showed they developed the same level of antibodies as teens and young adults who have had the vaccine.
Pfizer CEO Albert Bourla says they are ready to provide the new formulation pending FDA approval.
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to [email protected].